Table 2.
Baseline and in-hospital clinical characteristics in relation to the type of myocardial infarction.
| ST-Elevation MI 1 (65 Patients) | Non-ST-Elevation MI (147 Patients) | p-Value | |
|---|---|---|---|
| Baseline presentation | |||
| Age (years) | 67 ± 13 | 67 ± 11 | 0.93 |
| Male gender (%) | 60 | 69 | 0.21 |
| Hypertension history (%) | 71 | 82 | 0.07 |
| Diabetes history (%) | 35 | 37 | 0.88 |
| COPD history 2 (%) | 11 | 12 | 1.0 |
| Smoking (%) | 48 | 43 | 0.65 |
| Stroke history (%) | 6 | 9 | 0.59 |
| MI history (%) | 12 | 31 | 0.003 |
| Low-risk (%) | 20 | 28 | 0.24 |
| In-hospital characteristics | |||
| Length of hospital stay (d) | 8 (Q1: 7; Q3: 9) | 7 (Q1: 6; Q3: 10) | 0.19 |
| LVEF 3 (%) | 45 (Q1: 38; Q3: 55) | 50 (Q1: 40; Q3: 55) | 0.14 |
| LAD 4 culprit (%) | 45 | 33 | 0.12 |
| Multi-vessel disease (%) | 31 | 38 | 0.35 |
| Staged revascularization (%) | 20 | 22 | 0.86 |
| Ventricular arrhythmia (%) | 11 | 7 | 0.41 |
| GFR 5 (mL/min/1.73 m2) | 87 ± 35 | 73 ± 30 | 0.006 |
| RBC 6 transfusion (%) | 5 | 3 | 0.7 |
| Respiratory infections (%) | 15 | 16 | 1.0 |
| ACEI/ARB 7 (%) | 78 | 83 | 0.44 |
| B-blocker (%) | 80 | 84 | 0.56 |
| Loop diuretics (%) | 36 | 38 | 0.76 |
| Aldosterone antagonists (%) | 31 | 18 | 0.04 |
1 myocardial infarction; 2 chronic obstructive pulmonary disease; 3 left ventricular ejection fraction; 4 left anterior descending artery; 5 glomerular filtration rate; 6 red blood cell; 7 angiotensin converting enzyme inhibitor, angiotensin receptor blocker.